Rubella IgG & IgM Antibodies

Overview

Rubella, also known as German measles or three-day measles, is an acute, contagious viral disease caused by the Rubella virus (family Togaviridae, genus Rubivirus). The infection is usually mild in children and adults but becomes serious when it occurs during pregnancy, leading to Congenital Rubella Syndrome (CRS).

The Rubella IgM and IgG antibody tests are vital for diagnosing rubella and assessing immunity:

1. IgM antibodies appear early and indicate recent or active infection. They become detectable between 4 to 30 days after rash onset and may persist up to six months in CRS cases.
2. IgG antibodies indicate past infection or vaccination. They appear about four days after rash onset, peak in 1–2 weeks, and usually persist for life, confirming long-term immunity.

Testing is crucial for prenatal screening, outbreak investigations, and post-vaccination monitoring.

Symptoms

Rubella infection leads to the production of IgM and IgG antibodies and typically presents with:

1. General Symptoms: Fever, headache, malaise, and mild discomfort.
2. Respiratory Symptoms: Cough, sore throat, and runny nose.
3. Ocular Symptoms: Mild conjunctivitis or pink eye.
4. Lymphatic Symptoms: Swelling of lymph nodes, especially behind the ears and neck.
5. Skin Manifestations: Rash beginning on the face and spreading to the body, lasting about three days.
6. Joint Symptoms: Arthralgia (joint pain), more common in adults.

Rubella is most contagious 1–5 days after rash onset. Importantly, 25–50% of infected individuals may not develop symptoms, but they can still transmit the virus.

In pregnant women, rubella infection is dangerous, as it may cause CRS in the fetus, leading to defects such as cataracts, congenital heart disease, deafness, developmental delays, growth retardation, and microcephaly.

Causes

The primary cause of IgM and IgG antibody detection is infection with the Rubella virus, an enveloped, single-stranded RNA virus.

1. Transmission: Occurs via respiratory droplets or direct contact with secretions. The virus replicates in the nasopharynx and lymph nodes, spreads through viremia, and may cross the placenta during maternal infection.
2. Immune Response:
   1. IgM antibodies develop during acute infection, confirming recent exposure.
   1. IgG antibodies arise later, confirming immunity through past infection or vaccination.
3. Congenital Rubella Syndrome (CRS): Caused by maternal infection, particularly in the first trimester, when fetal infection risk is as high as 90%.

Risk Factors

Certain groups are at higher risk of rubella infection and related complications:

1. Unvaccinated individuals: Children or adults without the MMR (Measles, Mumps, Rubella) vaccine.
2. Pregnant women: Especially in the first trimester, where maternal infection leads to high CRS risk.
3. Infants born to infected mothers: At risk for congenital abnormalities.
4. Healthcare workers: Increased exposure to infected patients.
5. Close-contact environments: Schools, daycare centers, and crowded communities.
6. Immunocompromised individuals: May experience prolonged or severe infection.
7. Travelers: People visiting areas with poor vaccination coverage or rubella outbreaks.

Prevention

Rubella infection and its complications can be prevented through vaccination, hygiene practices, and proper testing:

1. Vaccination:
   1. The MMR vaccine (live attenuated) is the most effective preventive measure.
   2. Administered at 9–12 months, with a booster at 15–18 months or at school entry.
   3. Not recommended during pregnancy; women should be vaccinated before conception if non-immune.
2. Screening and Immunity Assessment:
   1. IgG antibody testing helps identify immunity in women of childbearing age.
   1. Prenatal screening ensures that non-immune women can be advised on vaccination after delivery.
3. Sample Collection and Handling:
   1. Collect 3 mL of blood in a red-capped tube and separate serum quickly.
   2. CSF samples (2 mL) may also be tested.
   3. Store samples at 2–8°C for 72 hours or freeze at –20°C for longer storage.
4. Infection Control:
   1. Isolate infected individuals during the contagious period.
   2. Encourage good respiratory hygiene, including handwashing and covering coughs.
5. Public Health Measures:
   1. Monitor outbreaks using IgM and IgG antibody testing.
   2. Provide community education on rubella transmission and vaccination